ロード中...
Antitumor and immunomodulatory effects of a novel multitarget inhibitor, CS2164, in mouse hepatocellular carcinoma models
As a novel orally active multitarget small molecule inhibitor, CS2164 has shown broad antitumor activities against several human tumor xenograft models in immune-compromised mice. However, the ability of CS2164 to modulate antitumor immunity in an immune-competent mouse tumor model remains undefined...
保存先:
| 出版年: | Anticancer Drugs |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6749973/ https://ncbi.nlm.nih.gov/pubmed/30998512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000791 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|